We are live on ! Find out more
CTV.WS

Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

Delisted

CTV.WS was delisted on the 12th of February, 2025.

0 hedge funds and large institutions have $0 invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $625 → $0 (-$625)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AS
Altshuler Shaham
Israel
-$625
Name Holding Trade Value Shares
Change
Change in
Stake
AS
1
Altshuler Shaham
Israel
-$625 -6,250 Closed

CTV.WS Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q2 2025, worth a combined $0 — down 100% from $625 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CTV.WS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Altshuler Shaham, exiting entirely with an estimated $625 sold.

  • 0 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q2 2025, down from 1 in Q1 2025.
  • Funds reported $0 of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2025 was Altshuler Shaham, an estimated $625 sold.

Based on aggregated 13F filings for Q2 2025.